{"transactions":[{"id":887956,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":1469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":4406,"derivative":{"underlying":"Common Stock","underlying_shares":1469},"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":887955,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":535,"price":12.7756,"value":6834.946,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $12.58 to $13.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9819,"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":887954,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-24T01:22:24.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":1469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":10354,"source":{"system":"sec-edgar","filing":"0000905148-26-000986","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000986/form4.xml","form_type":"4"}},{"id":909839,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":1527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1526,"derivative":{"underlying":"Common Stock","underlying_shares":1527},"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909838,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":73,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vested in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":73},"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909837,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":584,"price":10.0841,"value":5889.1144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8885,"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":909836,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:03:26.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":9469,"source":{"system":"sec-edgar","filing":"0000905148-26-000635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000635/form4.xml","form_type":"4"}},{"id":935312,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":false,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025."}],"balance_after":1609,"derivative":{"underlying":"Common Stock","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":935311,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":298,"price":8.1493,"value":2428.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $8.10 to $8.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7869,"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":935310,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-20T21:21:44.000Z","date":"2026-01-15","kind":"exercise","planned":false,"acquired":true,"shares":805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":8167,"source":{"system":"sec-edgar","filing":"0000905148-26-000251","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000251/form4.xml","form_type":"4"}},{"id":946300,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:25:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of forty-eight successive, substantially equal monthly installments measured from January 2, 2026, generally subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":27000,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000905148-26-000067","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000067/form4.xml","form_type":"4"}},{"id":1000103,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":false,"shares":75,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."}],"balance_after":73,"derivative":{"underlying":"Common Stock","underlying_shares":75},"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1000102,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"sale","planned":false,"acquired":false,"shares":25,"price":7.62,"value":190.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."}],"balance_after":7362,"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1000101,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T21:53:56.000Z","date":"2025-11-10","kind":"exercise","planned":false,"acquired":true,"shares":75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025."}],"balance_after":7387,"source":{"system":"sec-edgar","filing":"0000905148-25-003931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825003931/form4.xml","form_type":"4"}},{"id":1066335,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T21:24:51.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":2979,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0000905148-25-002982","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825002982/form4.xml","form_type":"4"}},{"id":1066334,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-14T21:24:51.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":476,"price":0.4163,"value":198.1588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":140065,"source":{"system":"sec-edgar","filing":"0000905148-25-002982","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825002982/form4.xml","form_type":"4"}},{"id":1066333,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-14T21:24:51.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":140541,"source":{"system":"sec-edgar","filing":"0000905148-25-002982","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825002982/form4.xml","form_type":"4"}},{"id":1150737,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-05-13T22:35:52.000Z","date":"2025-05-09","kind":"exercise","planned":false,"acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":4468,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-25-001607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001607/form4.xml","form_type":"4"}},{"id":1150736,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-13T22:35:52.000Z","date":"2025-05-13","kind":"sale","planned":false,"acquired":false,"shares":238,"price":0.3529,"value":83.9902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.3395 to $0.3622, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":139052,"source":{"system":"sec-edgar","filing":"0000905148-25-001607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001607/form4.xml","form_type":"4"}},{"id":1150735,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-13T22:35:52.000Z","date":"2025-05-12","kind":"sale","planned":false,"acquired":false,"shares":239,"price":0.3594,"value":85.8966,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.3431 to $0.4014, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":139290,"source":{"system":"sec-edgar","filing":"0000905148-25-001607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001607/form4.xml","form_type":"4"}},{"id":1150734,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-13T22:35:52.000Z","date":"2025-05-09","kind":"exercise","planned":false,"acquired":true,"shares":1490,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2025."}],"balance_after":139529,"source":{"system":"sec-edgar","filing":"0000905148-25-001607","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001607/form4.xml","form_type":"4"}},{"id":1242800,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-02-26T21:32:18.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":87319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vested in full on February 20, 2025. Under the Issuer's 2024 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2024 in the form of a fully-vested option."}],"balance_after":87319,"derivative":{"exercise_price":0.9209,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":87319},"source":{"system":"sec-edgar","filing":"0000905148-25-000780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000780/form4.xml","form_type":"4"}},{"id":1242799,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-02-26T21:32:18.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in a series of forty-eight successive equal monthly installments measured from February 20, 2025, generally subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":235000,"derivative":{"exercise_price":0.9209,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0000905148-25-000780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000780/form4.xml","form_type":"4"}},{"id":1242798,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-26T21:32:18.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":117500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of four successive equal annual installments measured from February 20, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":117500,"derivative":{"underlying":"Common Stock","underlying_shares":117500},"source":{"system":"sec-edgar","filing":"0000905148-25-000780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000780/form4.xml","form_type":"4"}},{"id":1271507,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-12T22:11:55.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":16095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":48286,"derivative":{"underlying":"Common Stock","underlying_shares":16095},"source":{"system":"sec-edgar","filing":"0000905148-25-000526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000526/form4.xml","form_type":"4"}},{"id":1271506,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-12T22:11:55.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":30534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":61067,"derivative":{"underlying":"Common Stock","underlying_shares":30534},"source":{"system":"sec-edgar","filing":"0000905148-25-000526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000526/form4.xml","form_type":"4"}},{"id":1271505,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-12T22:11:55.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":5958,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0000905148-25-000526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000526/form4.xml","form_type":"4"}},{"id":1271504,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:11:55.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":17527,"price":0.9242,"value":16198.4534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.90 to $0.9536, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128039,"source":{"system":"sec-edgar","filing":"0000905148-25-000526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000526/form4.xml","form_type":"4"}},{"id":1271503,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:11:55.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":48118,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":145566,"source":{"system":"sec-edgar","filing":"0000905148-25-000526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825000526/form4.xml","form_type":"4"}},{"id":1366472,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-13T21:21:53.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":7447,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-24-003057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824003057/form4.xml","form_type":"4"}},{"id":1366471,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T21:21:53.000Z","date":"2024-11-12","kind":"sale","planned":false,"acquired":false,"shares":224,"price":1.4008,"value":313.7792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":97448,"source":{"system":"sec-edgar","filing":"0000905148-24-003057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824003057/form4.xml","form_type":"4"}},{"id":1366470,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T21:21:53.000Z","date":"2024-11-11","kind":"sale","planned":false,"acquired":false,"shares":238,"price":1.3909,"value":331.0342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.36 to $1.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":97672,"source":{"system":"sec-edgar","filing":"0000905148-24-003057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824003057/form4.xml","form_type":"4"}},{"id":1366469,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T21:21:53.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":true,"shares":1490,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,792 shares purchased under the Issuer's Employee Stock Purchase Plan on August 30, 2024."}],"balance_after":97910,"source":{"system":"sec-edgar","filing":"0000905148-24-003057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824003057/form4.xml","form_type":"4"}},{"id":1435923,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-08-12T23:24:09.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":8937,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0000905148-24-002114","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002114/form4.xml","form_type":"4"}},{"id":1435922,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-12T23:24:09.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":120,"price":1.5719,"value":188.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.52 to $1.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":89628,"source":{"system":"sec-edgar","filing":"0000905148-24-002114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002114/form4.xml","form_type":"4"}},{"id":1435921,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-12T23:24:09.000Z","date":"2024-08-09","kind":"sale","planned":false,"acquired":false,"shares":345,"price":1.601,"value":552.345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.57 to $1.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":89748,"source":{"system":"sec-edgar","filing":"0000905148-24-002114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002114/form4.xml","form_type":"4"}},{"id":1435920,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-12T23:24:09.000Z","date":"2024-08-08","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":90093,"source":{"system":"sec-edgar","filing":"0000905148-24-002114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002114/form4.xml","form_type":"4"}},{"id":1503560,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:14:28.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13080},"source":{"system":"sec-edgar","filing":"0000905148-24-001612","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001612/form4.xml","form_type":"4"}},{"id":1503559,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-23T23:14:28.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":13080,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."}],"balance_after":88604,"source":{"system":"sec-edgar","filing":"0000905148-24-001612","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001612/form4.xml","form_type":"4"}},{"id":1520572,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-10T21:05:08.000Z","date":"2024-05-08","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":10426,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0000905148-24-001353","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001353/form4.xml","form_type":"4"}},{"id":1520571,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-10T21:05:08.000Z","date":"2024-05-09","kind":"sale","planned":false,"acquired":false,"shares":468,"price":1.4795,"value":692.406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75524,"source":{"system":"sec-edgar","filing":"0000905148-24-001353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001353/form4.xml","form_type":"4"}},{"id":1520570,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-10T21:05:08.000Z","date":"2024-05-08","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate 59 shares that were inadvertently reported as being sold on February 9 and February 12, 2024 in the Form 4 filed by the Reporting Person on February 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 6,439 shares purchased under the Issuer's Employee Stock Purchase Plan on February 29, 2024."}],"balance_after":75992,"source":{"system":"sec-edgar","filing":"0000905148-24-001353","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001353/form4.xml","form_type":"4"}},{"id":1544477,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:32:41.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":327,"price":46,"value":15042.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."}],"balance_after":327,"derivative":{"underlying":"Common Stock","underlying_shares":13080},"source":{"system":"sec-edgar","filing":"0000905148-24-001139","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001139/form4.xml","form_type":"4"}},{"id":1609886,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-29T23:16:33.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":35307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in full on February 21, 2024. Under the Issuer's 2023 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2023 in the form of a fully-vested option."}],"balance_after":35307,"derivative":{"exercise_price":1.46,"expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":35307},"source":{"system":"sec-edgar","filing":"0000905148-24-000824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000824/form4.xml","form_type":"4"}},{"id":1649045,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":30534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":91601,"derivative":{"underlying":"Common Stock","underlying_shares":30534},"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649044,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":11915,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649043,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":128761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests in a series of forty-eight successive equal monthly installments measured from January 15, 2024, generally subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":128761,"derivative":{"exercise_price":1.99,"expiration_date":"2034-02-07","underlying":"Common Stock","underlying_shares":128761},"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649042,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":64381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":64381,"derivative":{"underlying":"Common Stock","underlying_shares":64381},"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649041,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-12","kind":"sale","planned":false,"acquired":false,"shares":5412,"price":1.6647,"value":9009.3564,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68005,"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649040,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-09","kind":"sale","planned":false,"acquired":false,"shares":6319,"price":1.9166,"value":12110.9954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.8191 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":73417,"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1649039,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T02:45:35.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":32024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":79736,"source":{"system":"sec-edgar","filing":"0000905148-24-000585","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000585/form4.xml","form_type":"4"}},{"id":1743786,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-13T21:50:55.000Z","date":"2023-11-08","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":13405,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0000905148-23-001383","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823001383/form4.xml","form_type":"4"}},{"id":1743785,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-13T21:50:55.000Z","date":"2023-11-10","kind":"sale","planned":false,"acquired":false,"shares":235,"price":1.2256,"value":288.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.19 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47712,"source":{"system":"sec-edgar","filing":"0000905148-23-001383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823001383/form4.xml","form_type":"4"}},{"id":1743784,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-13T21:50:55.000Z","date":"2023-11-09","kind":"sale","planned":false,"acquired":false,"shares":234,"price":1.2707,"value":297.3438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.23 to $1.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47947,"source":{"system":"sec-edgar","filing":"0000905148-23-001383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823001383/form4.xml","form_type":"4"}},{"id":1743783,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-11-13T21:50:55.000Z","date":"2023-11-08","kind":"exercise","planned":false,"acquired":true,"shares":1489,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":48181,"source":{"system":"sec-edgar","filing":"0000905148-23-001383","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823001383/form4.xml","form_type":"4"}},{"id":1810799,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-10T23:28:57.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":3972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3972},"source":{"system":"sec-edgar","filing":"0000905148-23-000666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000666/form4.xml","form_type":"4"}},{"id":1810798,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-10T23:28:57.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":14894,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0000905148-23-000666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000666/form4.xml","form_type":"4"}},{"id":1810797,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-10T23:28:57.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":849,"price":1.2669,"value":1075.5981,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":46692,"source":{"system":"sec-edgar","filing":"0000905148-23-000666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000666/form4.xml","form_type":"4"}},{"id":1810796,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-10T23:28:57.000Z","date":"2023-08-09","kind":"sale","planned":false,"acquired":false,"shares":850,"price":1.3883,"value":1180.055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47541,"source":{"system":"sec-edgar","filing":"0000905148-23-000666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000666/form4.xml","form_type":"4"}},{"id":1810795,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-10T23:28:57.000Z","date":"2023-08-08","kind":"exercise","planned":false,"acquired":true,"shares":5462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":48391,"source":{"system":"sec-edgar","filing":"0000905148-23-000666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000666/form4.xml","form_type":"4"}},{"id":1813775,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-07T21:31:38.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6172,"price":1.62,"value":9998.64,"ownership":{"direct":true},"balance_after":42929,"source":{"system":"sec-edgar","filing":"0000905148-23-000625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000625/form4.xml","form_type":"4"}},{"id":1822780,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-26T22:14:55.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":11564,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This Replacement Option vests as follows: 8,864 shares of Common Stock underlying this Replacement Option vest on August 1, 2024, and the remaining 2,700 shares of Common Stock underlying this Replacement Option vest in 31 successive, equal monthly installments beginning on August 1, 2024."}],"balance_after":11564,"derivative":{"exercise_price":1.2,"expiration_date":"2033-07-23","underlying":"Common Stock","underlying_shares":11564},"source":{"system":"sec-edgar","filing":"0000905148-23-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000511/form4.xml","form_type":"4"}},{"id":1822779,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-26T22:14:55.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully vested as of the grant date."}],"balance_after":0,"derivative":{"exercise_price":20.67,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":31055},"source":{"system":"sec-edgar","filing":"0000905148-23-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000511/form4.xml","form_type":"4"}},{"id":1822778,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-26T22:14:55.000Z","date":"2023-07-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 23, 2023, the Issuer made an offer (the \"Tender Offer\") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, \"Surrendered Options\") for new options with terms determined in accordance with the terms of the Tender Offer (\"Replacement Options\"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person elected to participate in the Tender Offer and received 11,564 Replacement Options with an exercise price of $1.20 per share in exchange for 56,654 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was scheduled to vest in a series of 60 successive, equal monthly installments measured from February 23, 2021."}],"balance_after":0,"derivative":{"exercise_price":20.67,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":25599},"source":{"system":"sec-edgar","filing":"0000905148-23-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000511/form4.xml","form_type":"4"}},{"id":1822777,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-26T22:14:55.000Z","date":"2021-02-23","kind":"grant","planned":false,"acquired":true,"shares":31055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully vested as of the grant date."}],"balance_after":31055,"derivative":{"exercise_price":20.67,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":31055},"source":{"system":"sec-edgar","filing":"0000905148-23-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000511/form4.xml","form_type":"4"}},{"id":1822776,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-07-26T22:14:55.000Z","date":"2021-02-23","kind":"grant","planned":false,"acquired":true,"shares":25599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was scheduled to vest in a series of 60 successive, equal monthly installments measured from February 23, 2021."}],"balance_after":25599,"derivative":{"exercise_price":20.67,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":25599},"source":{"system":"sec-edgar","filing":"0000905148-23-000511","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000511/form4.xml","form_type":"4"}},{"id":1898050,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-11T00:16:30.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":false,"shares":3972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":3972,"derivative":{"underlying":"Common Stock","underlying_shares":3972},"source":{"system":"sec-edgar","filing":"0001140361-23-023968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123023968/form4.xml","form_type":"4"}},{"id":1898049,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-11T00:16:30.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":16384,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0001140361-23-023968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123023968/form4.xml","form_type":"4"}},{"id":1898048,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-11T00:16:30.000Z","date":"2023-05-10","kind":"sale","planned":false,"acquired":false,"shares":474,"price":1.5761,"value":747.0714,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.5332 to $1.615, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":36757,"source":{"system":"sec-edgar","filing":"0001140361-23-023968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123023968/form4.xml","form_type":"4"}},{"id":1898047,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-11T00:16:30.000Z","date":"2023-05-09","kind":"sale","planned":false,"acquired":false,"shares":1223,"price":1.5664,"value":1915.7072,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares of the Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.6039, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37231,"source":{"system":"sec-edgar","filing":"0001140361-23-023968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123023968/form4.xml","form_type":"4"}},{"id":1898046,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-11T00:16:30.000Z","date":"2023-05-08","kind":"exercise","planned":false,"acquired":true,"shares":5461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 shares purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2023."}],"balance_after":38454,"source":{"system":"sec-edgar","filing":"0001140361-23-023968","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123023968/form4.xml","form_type":"4"}},{"id":1972886,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-03-03T21:16:03.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":52531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option."}],"balance_after":52531,"derivative":{"exercise_price":2,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":52531},"source":{"system":"sec-edgar","filing":"0001140361-23-010024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123010024/form4.xml","form_type":"4"}},{"id":2022531,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-10T23:40:32.000Z","date":"2023-02-08","kind":"exercise","acquired":false,"shares":3971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":7944,"derivative":{"underlying":"Common Stock","underlying_shares":3971},"source":{"system":"sec-edgar","filing":"0001140361-23-006073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123006073/form4.xml","form_type":"4"}},{"id":2022530,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-10T23:40:32.000Z","date":"2023-02-08","kind":"exercise","acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":17873,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0001140361-23-006073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123006073/form4.xml","form_type":"4"}},{"id":2022529,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-10T23:40:32.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":122135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."}],"balance_after":122135,"derivative":{"underlying":"Common Stock","underlying_shares":122135},"source":{"system":"sec-edgar","filing":"0001140361-23-006073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123006073/form4.xml","form_type":"4"}},{"id":2022528,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-10T23:40:32.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":1999,"price":1.7991,"value":3596.4009,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares of Issuer's common stock were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22993,"source":{"system":"sec-edgar","filing":"0001140361-23-006073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123006073/form4.xml","form_type":"4"}},{"id":2022527,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-10T23:40:32.000Z","date":"2023-02-08","kind":"exercise","acquired":true,"shares":5461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":24992,"source":{"system":"sec-edgar","filing":"0001140361-23-006073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123006073/form4.xml","form_type":"4"}},{"id":2108490,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-21T23:02:51.000Z","date":"2022-11-21","kind":"grant","acquired":true,"shares":4347,"price":1.15,"value":4999.05,"ownership":{"direct":true},"balance_after":19531,"source":{"system":"sec-edgar","filing":"0001140361-22-042598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042598/form4.xml","form_type":"4"}},{"id":2119931,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-11T02:02:42.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":3972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":11915,"derivative":{"underlying":"Common Stock","underlying_shares":3972},"source":{"system":"sec-edgar","filing":"0001140361-22-041082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041082/form4.xml","form_type":"4"}},{"id":2119930,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-11T02:02:42.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":19363,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0001140361-22-041082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041082/form4.xml","form_type":"4"}},{"id":2119929,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:42.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":753,"price":1.0175,"value":766.1775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15184,"source":{"system":"sec-edgar","filing":"0001140361-22-041082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041082/form4.xml","form_type":"4"}},{"id":2119928,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:42.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":952,"price":1.0418,"value":991.7936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.00 to $1.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15937,"source":{"system":"sec-edgar","filing":"0001140361-22-041082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041082/form4.xml","form_type":"4"}},{"id":2119927,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-11T02:02:42.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":5461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."}],"balance_after":16889,"source":{"system":"sec-edgar","filing":"0001140361-22-041082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122041082/form4.xml","form_type":"4"}},{"id":2189306,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-10T22:53:41.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":3972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":15887,"derivative":{"underlying":"Common Stock","underlying_shares":3972},"source":{"system":"sec-edgar","filing":"0001140361-22-029133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029133/form4.xml","form_type":"4"}},{"id":2189305,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-10T22:53:41.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":1490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":20852,"derivative":{"underlying":"Common Stock","underlying_shares":1490},"source":{"system":"sec-edgar","filing":"0001140361-22-029133","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029133/form4.xml","form_type":"4"}},{"id":2189304,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-10T22:53:41.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":1673,"price":2.5282,"value":4229.6786,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11428,"source":{"system":"sec-edgar","filing":"0001140361-22-029133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029133/form4.xml","form_type":"4"}},{"id":2189303,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-10T22:53:41.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":5462,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."}],"balance_after":13101,"source":{"system":"sec-edgar","filing":"0001140361-22-029133","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122029133/form4.xml","form_type":"4"}},{"id":2274681,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-12T01:42:34.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":3972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":19859,"derivative":{"underlying":"Common Stock","underlying_shares":3972},"source":{"system":"sec-edgar","filing":"0001140361-22-018736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018736/form4.xml","form_type":"4"}},{"id":2274680,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-12T01:42:34.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":22342,"derivative":{"underlying":"Common Stock","underlying_shares":1489},"source":{"system":"sec-edgar","filing":"0001140361-22-018736","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018736/form4.xml","form_type":"4"}},{"id":2274679,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-12T01:42:34.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":1583,"price":1.83,"value":2896.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These Shares were sold automatically to cover taxes upon the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7639,"source":{"system":"sec-edgar","filing":"0001140361-22-018736","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018736/form4.xml","form_type":"4"}},{"id":2274678,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-12T01:42:34.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":5461,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock (each, a \"Share\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 1,157 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively."}],"balance_after":9222,"source":{"system":"sec-edgar","filing":"0001140361-22-018736","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122018736/form4.xml","form_type":"4"}},{"id":2335307,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-14T21:51:26.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":6162,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6162,"derivative":{"exercise_price":2.29,"exercise_date":"2022-03-10","expiration_date":"2032-03-09","underlying":"Common Stock","underlying_shares":6162},"source":{"system":"sec-edgar","filing":"0001567619-22-006920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922006920/doc1.xml","form_type":"4"}},{"id":2335306,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-14T21:51:26.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":4211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"shares","element":"transactionShares","label":"F3","text":"On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 4,211 shares underlying the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 10, 2022, the Compensation Committee confirmed the performance criteria were met for fiscal year 2021, resulting in the vesting of 4,211 shares underlying the option."}],"balance_after":8423,"derivative":{"exercise_price":0.77,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":4211},"source":{"system":"sec-edgar","filing":"0001567619-22-006920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922006920/doc1.xml","form_type":"4"}},{"id":2335305,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-14T21:51:26.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":4212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"shares","element":"transactionShares","label":"F2","text":"On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the \"Compensation Committee\") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 4,212 shares underlying the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 15, 2020, the Reporting Person was granted an option to purchase 8,423 shares (as-adjusted for the 0.1684664-for-1 reverse stock split effected on October 19, 2020), the vesting of which was subject to the Issuer's satisfaction of certain performance criteria for each of the 2020 and 2021 fiscal years."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 23, 2021, the Compensation Committee of the Issuer's board of directors (the \"Compensation Committee\") confirmed the performance criteria were met for fiscal year 2020, resulting in the vesting of 4,212 shares underlying the option."}],"balance_after":4212,"derivative":{"exercise_price":0.77,"expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":4212},"source":{"system":"sec-edgar","filing":"0001567619-22-006920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922006920/doc1.xml","form_type":"4"}},{"id":2404180,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T00:09:23.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":23831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":23831,"derivative":{"underlying":"Common Stock","underlying_shares":23831},"source":{"system":"sec-edgar","filing":"0001140361-22-004588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122004588/form4.xml","form_type":"4"}},{"id":2404179,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":65172,"kind":"person","name":"O'Kane Kieran","position":1,"cik":"0001828131","reported_name":"O'Kane Kieran","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-11T00:09:23.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":23831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date."}],"balance_after":23831,"derivative":{"underlying":"Common Stock","underlying_shares":23831},"source":{"system":"sec-edgar","filing":"0001140361-22-004588","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122004588/form4.xml","form_type":"4"}}]}